Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...

It follows a similar lawsuit against Pfizer and BioNTech filed in April in which GSK alleges the companies were in violation ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

COVID has changed so much from the first few years of the pandemic, when people got those first vaccines in 2021,” said Dr. Doug Pogue, president of BJC Medical Group.

In a new study examining people with opioid or alcohol use disorder, prescriptions for Ozempic, Wegovy, Mounjaro, and ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

Moderna is facing allegations that it misused innovations from researchers at Northwestern University to develop its mRNA COVID-19 vaccines, which became widely available to the public in 2021 to ...

Westchester Community Health Center, which used to be called the Greenburgh Neighborhood Health Center, will be offering ...

After a lengthy COVID-19 surge this summer, the Bay Area is about to enter the winter respiratory virus season. Explore our ...